Childhood Cancer Incidence, New York City, 2014-2018

Source: New York State Cancer Registry

Site of Cancer Ages 0-4 Ages 5-9 Ages 10-14 Ages 15-19 Combined Ages 0-14 Combined Ages 0-19
Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 95% CI Avg Annual Cases Rate per 1,000,000 95% CI
All Invasive Malignant Tumors 137.8 249.5 71.2 147.0 91.4 199.9 133.2 292.6 300.4 197.7 187.7-208.0 433.6 221.6 212.3-231.1
I Leukemias 46.4 84.0 22.2 45.8 16.4 35.9 24.6 54.0 85.0 54.8 49.7-60.3 109.6 54.6 50.1-59.4
   I(a) Lymphoid leukemias 31.4 56.9 17.4 35.9 8.6 18.8 13.6 29.9 57.4 37.0 32.8-41.6 71.0 35.2 31.6-39.1
   I(b) Acute myeloid leukemia 6.0 10.9 1.8 3.7 3.2 7.0 5.4 11.9 11.0 7.1 5.3-9.3 16.4 8.3 6.6-10.3
II Lymphomas and reticuloendothelial neoplasms 11.0 19.9 10.2 21.1 18.8 41.1 30.2 66.3 40.0 27.5 23.8-31.6 70.2 37.2 33.4-41.4
   II(a) Hodgkin lymphoma 0.4 0.7 0.8 1.7 7.4 16.2 15.8 34.7 8.6 6.3 4.6-8.5 24.4 13.4 11.2-16.0
   II(b,c,d) Non-Hodgkin lymphomas 10.4 18.8 9.4 19.4 11.2 24.5 13.8 30.3 31.0 20.9 17.7-24.5 44.8 23.3 20.3-26.5
III CNS & misc intracranial & intraspinal neoplasms 23.4 42.4 18.0 37.2 17.0 37.2 10.2 22.4 58.4 38.9 34.5-43.6 68.6 34.7 31.2-38.6
   III(a) Ependymomas and choroid plexus tumor 3.0 5.4 1.4 2.9 1.4 3.1 0.4 0.9 5.8 3.8 2.5-5.5 6.2 3.1 2.1-4.3
   III(b) Astrocytoma 11.2 20.3 8.8 18.2 8.8 19.2 5.4 11.9 28.8 19.3 16.2-22.7 34.2 17.4 14.9-20.2
   III(c) Intracranial and intraspinal embryonal tum 5.4 9.8 3.2 6.6 2.2 4.8 1.0 2.2 10.8 7.0 5.2-9.1 11.8 5.8 4.4-7.5
   III(d) Other gliomas 2.6 4.7 3.6 7.4 4.0 8.7 2.4 5.3 10.2 7.0 5.2-9.2 12.6 6.6 5.0-8.4
IV Neuroblastoma and other peripheral nervous cell tumors 19.0 34.4 3.4 7.0 0.8 1.7 1.0 2.2 23.2 13.9 11.5-16.7 24.2 11.0 9.1-13.1
   IV(a) Neuroblastoma and ganglioneuroblastoma 19.0 34.4 3.4 7.0 0.8 1.7 0.6 1.3 23.2 13.9 11.5-16.7 23.8 10.7 8.9-12.9
V Retinoblastoma 8.4 15.2 0.4 0.8 0.2 0.4 0.0 0.0 9.0 5.2 3.8-7.0 9.0 3.9 2.8-5.2
VI Renal tumors 9.6 17.4 2.4 5.0 1.4 3.1 0.8 1.8 13.4 8.3 6.4-10.6 14.2 6.7 5.2-8.4
   VI(a) Nephroblastoma and other nonepithelial rena 9.6 17.4 2.4 5.0 0.4 0.9 0.0 0.0 12.4 7.6 5.8-9.7 12.4 5.7 4.3-7.3
VII Hepatic tumors 4.0 7.2 0.6 1.2 0.4 0.9 1.0 2.2 5.0 3.0 1.9-4.5 6.0 2.8 1.9-4.0
   VII(a) Hepatoblastoma 4.0 7.2 0.4 0.8 0.0 0.0 0.0 0.0 4.4 2.6 1.6-3.9 4.4 1.9 1.2-2.9
VIII Malignant bone tumors 1.4 2.5 4.4 9.1 10.2 22.3 9.4 20.7 16.0 11.5 9.1-14.3 25.4 13.8 11.5-16.4
   VIII(a) Osteosarcoma 0.0 0.0 2.0 4.1 6.8 14.9 5.4 11.9 8.8 6.5 4.7-8.6 14.2 7.8 6.1-9.8
   VIII(c) Ewing tumor and related sarcomas of bone 0.8 1.4 1.8 3.7 1.8 3.9 2.0 4.4 4.4 3.1 1.9-4.6 6.4 3.4 2.3-4.8
IX Soft tissue and other extraosseous sarcomas 7.0 12.7 5.0 10.3 9.0 19.7 8.6 18.9 21.0 14.3 11.6-17.3 29.6 15.4 13.0-18.1
   IX(a) Rhabdomyosarcoma 4.2 7.6 2.2 4.5 2.0 4.4 1.4 3.1 8.4 5.5 3.9-7.4 9.8 4.9 3.6-6.4
X Germ cell & trophoblastic tumors & gonadal neoplasms 4.6 8.3 2.2 4.5 6.4 14.0 12.8 28.1 13.2 8.9 6.9-11.4 26.0 13.7 11.5-16.3
   X(a) Intracranial and intraspinal germ cell tumo 0.4 0.7 0.4 0.8 2.4 5.2 0.8 1.8 3.2 2.3 1.3-3.7 4.0 2.2 1.3-3.3
   X(c) Malignant gonadal germ cell tumor 1.2 2.2 1.4 2.9 3.8 8.3 9.2 20.2 6.4 4.5 3.1-6.3 15.6 8.5 6.7-10.5
XI Other malignant epithelial neoplasms and malignant melanomas 1.0 1.8 1.8 3.7 10.0 21.9 34.2 75.1 12.8 9.3 7.1-11.8 47.0 25.8 22.6-29.3
   XI(b) Thyroid carcinoma 0.0 0.0 0.6 1.2 4.4 9.6 19.8 43.5 5.0 3.7 2.4-5.4 24.8 13.7 11.4-16.3
   XI(d) Malignant melanoma 0.6 1.1 0.2 0.4 0.0 0.0 2.0 4.4 0.8 0.5 0.1-1.3 2.8 1.5 0.8-2.5
XII Other and unspecified malignant neoplasms 0.6 1.1 0.4 0.8 0.2 0.4 0.4 0.9 1.2 0.8 0.3-1.7 1.6 0.8 0.3-1.6

Notes

  • Incidence data are provisional, November 2020.
  • Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases per year are unstable and should be used with caution.
  • Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).